> Back to EJC

2016 editions

  • December 2016
    Joao Incio on mechanisms to explain why obesity promotes cancer.
  • November 2016
    Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer.
  • October 2016
    Ruth Muschel on a new target for treatments for colorectal cancer.
  • September 2016
    Freddie Hamdy on the effectiveness of treatments for prostate cancer.
  • August 2016
    Moshe Oren discusses the effects of the microenvironment on cancer cells.
  • July 2016
    Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
  • June 2016
    Key advances in clinical trials.
  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – August 2016

Loading EJC News Focus video

New insights into a cancer cell's microenvironment

The microenvironment of cancer cells holds clues to both the natural progression of a cancer and the likely success of some treatments, notably immunotherapy. Its role is increasingly understood and was explored in depth at the EACR Congress (Manchester, UK; 9-12 July).

Moshe Oren (Weizmann Institute, Israel), a former EACR President and member of the Congress organising committee, said that understanding what's happening in the cancer cell is only part of the story. In this month's EJC News Focus, he tells Helen Saul that the cross talk between a cancer cell and its environment is key to a fuller understanding.